Hydroxyethylstarch 130/0.4

DRUG3 trials

Sponsors

Fresenius Kabi, Maisonneuve-Rosemont Hospital, University Hospital, Caen

Conditions

Cardiac Output, LowCesarean SectionFluid TherapyHypotensionHypovolemiaImpaired Oxygen DeliveryIntraoperative ComplicationsObstetric Anesthesia

Phase 4

Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation

TerminatedNCT00308100

Fresenius KabiIntraoperative Complications

Start: 2005-10-31End: 2008-07-31Updated: 2009-01-15

ED50 Determination of Hydroxyethylstarch for Treatment of Hypotension During Cesarean Section Under Spinal Anesthesia

Maisonneuve-Rosemont HospitalCesarean Section, Fluid Therapy, Hypotension +2

Start: 2011-10-31End: 2013-06-30Target: 30Updated: 2013-02-15

Unknown Phase

Observational Study of Oxygen Delivery During a Fractional Fluid Expansion

CompletedNCT01826253

University Hospital, CaenCardiac Output, Low, Hypovolemia, Impaired Oxygen Delivery

Start: 2013-04-30End: 2014-06-30Target: 20Updated: 2014-06-16